Page last updated: 2024-08-24

imiquimod and methyl-thiohydantoin-tryptophan

imiquimod has been researched along with methyl-thiohydantoin-tryptophan in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, H; Duan, X; Huang, Y; Jin, Z; Liu, N; Liu, X; Ming, Z; Zhang, S	1

Other Studies

1 other study(ies) available for imiquimod and methyl-thiohydantoin-tryptophan

Article	Year
Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation. Cell death & disease, 2020, 02-19, Volume: 11, Issue:2 Topics: Acrylamides; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Female; HaCaT Cells; Humans; Imidazoles; Imiquimod; Indoles; Inflammation Mediators; Keratinocytes; Mice, Inbred BALB C; Necroptosis; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Psoriasis; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; Skin; Sulfonamides	2020

Article

Year

Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation.

Cell death & disease, 2020, 02-19, Volume: 11, Issue:2

Topics: Acrylamides; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Female; HaCaT Cells; Humans; Imidazoles; Imiquimod; Indoles; Inflammation Mediators; Keratinocytes; Mice, Inbred BALB C; Necroptosis; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Psoriasis; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; Skin; Sulfonamides

2020